Emerging multidrug-resistant Candida species

Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America

Pappas, P. G., Kauffman, C. A., Andes, D. R., Clancy, C. J., Marr, K. A., Ostrosky-Zeichner, L., Reboli, A. C., Schuster, M. G., Vazquez, J. A., Walsh, T. J., et al. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/civ933 · Cited by 4,200

Clinical Practice Guidelines for the Management Candidiasis: 2009 Update by the Infectious Diseases Society of America

Pappas, P. G., Kauffman, C. A., Andes, D., Benjamin, D. K., Calandra, T. F., Edwards, J. E., Filler, S. G., Fisher, J. F., Kullberg, B.-J., Zeichner, L. O., et al. (2009) · Clinical Infectious Diseases · doi:10.1086/596757 · Cited by 3,191

Simultaneous Emergence of Multidrug-Resistant Candida auris on 3 Continents Confirmed by Whole-Genome Sequencing and Epidemiological Analyses

Lockhart, S. R., Etienne, K. A., Vallabhaneni, S., Farooqi, J., Chowdhary, A., Govender, N. P., Colombo, A. L., Calvo, B., Cuomo, C. A., Desjardins, C. A., et al. (2017) · Clinical Infectious Diseases · doi:10.1093/cid/ciw691 · Cited by 1,662

Candida auris sp. nov., a novel ascomycetous yeast isolated from the external ear canal of an inpatient in a Japanese hospital

Satoh, K., Makimura, K., Hasumi, Y., Nishiyama, Y., Uchida, K., & Yamaguchi, H. (2009) · Microbiology and Immunology · doi:10.1111/j.1348-0421.2008.00083.x · Cited by 1,381

Executive Summary: Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America

Pappas, P. G., Kauffman, C. A., Andes, D. R., Clancy, C. J., Marr, K. A., Ostrosky-Zeichner, L., Reboli, A. C., Schuster, M. G., Vazquez, J. A., Walsh, T. J., et al. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/civ1194 · Cited by 1,298

ESCMID† and ECMM‡ joint clinical guidelines for the diagnosis and management of mucormycosis 2013

Cornely, O. A., Arıkan-Akdağlı, S., Dannaoui, É., Groll, A. H., Lagrou, K., Chakrabarti, A., Lanternier, F., Pagano, L., Skiada, A., Akova, M., et al. (2014) · Clinical Microbiology and Infection · doi:10.1111/1469-0691.12371 · Cited by 864

Increasing Echinocandin Resistance in Candida glabrata: Clinical Failure Correlates With Presence of FKS Mutations and Elevated Minimum Inhibitory Concentrations

Alexander, B. D., Johnson, M. D., Pfeiffer, C. D., Jiménez-Ortigosa, C., Catania, J., Booker, R., Castanheira, M., Messer, S. A., Perlin, D. S., & Pfaller, M. A. (2013) · Clinical Infectious Diseases · doi:10.1093/cid/cit136 · Cited by 778

First hospital outbreak of the globally emerging Candida auris in a European hospital

Schelenz, S., Hagen, F., Rhodes, J. L., Abdolrasouli, A., Chowdhary, A., Hall, A., Ryan, L., Shackleton, J., Trimlett, R., Meis, J. F., et al. (2016) · Antimicrobial Resistance & Infection Control · doi:10.1186/s13756-016-0132-5 · Cited by 768

Candida auris: A rapidly emerging cause of hospital-acquired multidrug-resistant fungal infections globally

Chowdhary, A., Sharma, C., & Meis, J. F. (2017) · PLOS Pathogens · doi:10.1371/journal.ppat.1006290 · Cited by 750

Results from the ARTEMIS DISK Global Antifungal Surveillance Study, 1997 to 2007: a 10.5-Year Analysis of Susceptibilities of Candida Species to Fluconazole and Voriconazole as Determined by CLSI Standardized Disk Diffusion

Pfaller, M. A., Diekema, D. J., Gibbs, D. L., Newell, V. A., Ellis, D., Tullio, V., Rodloff, A., Fu, W., & Ling, T. A. (2010) · Journal of Clinical Microbiology · doi:10.1128/jcm.02117-09 · Cited by 718

Global trends in the distribution of Candida species causing candidemia

Guinea, J. (2014) · Clinical Microbiology and Infection · doi:10.1111/1469-0691.12539 · Cited by 680

Multidrug-Resistant Candida auris Misidentified as Candida haemulonii: Characterization by Matrix-Assisted Laser Desorption Ionization–Time of Flight Mass Spectrometry and DNA Sequencing and Its Antifungal Susceptibility Profile Variability by Vitek 2, CLSI Broth Microdilution, and Etest Method

Kathuria, S., Singh, P. K., Sharma, C., Prakash, A., Masih, A., Kumar, A., Meis, J. F. G. M., & Chowdhary, A. (2015) · Journal of Clinical Microbiology · doi:10.1128/jcm.00367-15 · Cited by 553

First Three Reported Cases of Nosocomial Fungemia Caused by Candida auris

Lee, W. G., Shin, J. H., Uh, Y., Kang, M. G., Kim, S. H., Park, K. H., & Jang, H. (2011) · Journal of Clinical Microbiology · doi:10.1128/jcm.00319-11 · Cited by 524

Amphotericin B: spectrum and resistance

Ellis, D. (2002) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/49.suppl_1.7 · Cited by 474

First report of Candida auris in America: Clinical and microbiological aspects of 18 episodes of candidemia

Calvo, B., Melo, A. S. D. A., Mena, A. J. P., Hernandez, M., Francisco, E. C., Hagen, F., Meis, J. F. G. M., & Colombo, A. L. (2016) · Journal of Infection · doi:10.1016/j.jinf.2016.07.008 · Cited by 448

Epidemiology and outcomes of candidemia in 3648 patients: data from the Prospective Antifungal Therapy (PATH Alliance®) registry, 2004–2008

Pfaller, M. A., Neofytos, D., Diekema, D. J., Azie, N. E., Meier‐Kriesche, H., Quan, S.-P., & Horn, D. (2012) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2012.10.003 · Cited by 391

Frequency of decreased susceptibility and resistance to echinocandins among fluconazole-resistant bloodstream isolates of Candida glabrata

Pfaller, M. A., Castanheira, M., Lockhart, S. R., Ahlquist, A. M., Messer, S. A., & Jones, R. N. (2012) · Journal of Clinical Microbiology · doi:10.1128/jcm.06112-11 · Cited by 377

Epidemiology of candidemia in Latin America: a laboratory-based survey

Nucci, M., Queiroz-Telles, F., Alvarado-Matute, T., Tiraboschi, I. N., Cortes, J., Zurita, J., Guzman-Blanco, M., Santolaya, M. E., Thompson, L., Sifuentes-Osornio, J., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0059373 · Cited by 374

Echinocandin resistance in Candida.

Perlin, D. S. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/civ791 · Cited by 374

Candida auris candidaemia in Indian ICUs: analysis of risk factors

Rudramurthy, S. M., Chakrabarti, A., Paul, R. A., Sood, P., Kaur, H., Capoor, M. R., Kindo, A. J., Marak, R. S. K., Arora, A., Sardana, R., et al. (2017) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkx034 · Cited by 357

Candidaemia in Europe: epidemiology and resistance

Tortorano, A. M., Kibbler, C. C., Pemán, J., Bernhardt, H., Klingspor, L., & Grillot, R. (2006) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2006.01.002 · Cited by 349

Comparative Pathogenicity of United Kingdom Isolates of the Emerging Pathogen Candida auris and Other Key Pathogenic Candida Species

Borman, A. M., Szekely, A., & Johnson, E. M. (2016) · mSphere · doi:10.1128/msphere.00189-16 · Cited by 333

The changing epidemiology of invasive candidiasis

Hachem, R. Y., Hanna, H. A., Kontoyiannis, D. P., Jiang, Y., & RAAD, I. I. (2008) · Cancer · doi:10.1002/cncr.23466 · Cited by 330

Worrisome trends in incidence and mortality of candidemia in intensive care units (Paris area, 2002–2010)

The French Mycosis Study Group, Lortholary, O., Renaudat, C., Sitbon, K., Madec, Y., Denoeud‐Ndam, L., Wolff, M., Fontanet, A. L., Bretagne, S., & Dromer, F. (2014) · Intensive Care Medicine · doi:10.1007/s00134-014-3408-3 · Cited by 310

Candida haemuloniiand Closely Related Species at 5 University Hospitals in Korea: Identification, Antifungal Susceptibility, and Clinical Features

Kim, M., Shin, J. H., Sung, H., Lee, K., Kim, E.-C., Ryoo, N. H., Lee, J., Jung, S., Park, K. H., Kee, S., et al. (2009) · Clinical Infectious Diseases · doi:10.1086/597108 · Cited by 310

Multidrug-Resistant Candida haemulonii and C. auris , Tel Aviv, Israel

Ben-Ami, R., Berman, J., Novikov, A., Bash, E., Shachor-Meyouhas, Y., Zakin, S., Maor, Y., Tarabia, J., Schechner, V., Adler, A., et al. (2017) · Emerging Infectious Diseases · doi:10.3201/eid2302.161486 · Cited by 297

Prevalent mutator genotype identified in fungal pathogen Candida glabrata promotes multi-drug resistance.

Healey, K. R., Zhao, Y., Perez, W. B., Lockhart, S. R., Sobel, J. D., Farmakiotis, D., Kontoyiannis, D. P., Sanglard, D., Taj-Aldeen, S. J., Alexander, B. D., et al. (2016) · Nature Communications · doi:10.1038/ncomms11128 · Cited by 276

Candida auris–Associated Candidemia, South Africa

Magobo, R. E., Corcoran, C., Seetharam, S., & Govender, N. P. (2014) · Emerging Infectious Diseases · doi:10.3201/eid2007.131765 · Cited by 259

Role of ATP-Binding-Cassette Transporter Genes in High-Frequency Acquisition of Resistance to Azole Antifungals in Candida glabrata

Sanglard, D., Ischer, F., & Bille, J. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.4.1174-1183.2001 · Cited by 247

Invasive Infections with Multidrug-Resistant Yeast Candida auris , Colombia

Morales-López, S. E., Parra‐Giraldo, C. M., Ceballos-Garzón, A., Martínez, H. P., Rodríguez, G. J., Álvarez, C., & Rodríguez, J. Y. (2016) · Emerging infectious diseases · doi:10.3201/eid2301.161497 · Cited by 244

Reclassification of the Candida haemulonii Complex as Candida haemulonii (C. haemulonii Group I), C. duobushaemulonii sp. nov. (C. haemulonii Group II), and C. haemulonii var. vulnera var. nov.: Three Multiresistant Human Pathogenic Yeasts

Cendejas‐Bueno, E., Kolecka, A., Alastruey‐Izquierdo, A., Theelen, B., Groenewald, M., Kostrzewa, M., Cuenca‐Estrella, M., Gómez‐López, A., & Boekhout, T. (2012) · Journal of Clinical Microbiology · doi:10.1128/jcm.02248-12 · Cited by 234

Pdr1 regulates multidrug resistance in Candida glabrata : gene disruption and genome‐wide expression studies

Vermitsky, J., Earhart, K. D., Smith, W. L., Homayouni, R., Edlind, T. D., & Rogers, P. D. (2006) · Molecular Microbiology · doi:10.1111/j.1365-2958.2006.05235.x · Cited by 233

Role of FKS mutations in Candida glabrata: MIC values, echinocandin resistance, and multidrug resistance

Pham, C. D., Iqbal, N., Bolden, C. B., Kuykendall, R. J., Harrison, L. H., Farley, M. M., Schaffner, W., Beldavs, Z. G., Chiller, T. M., Park, B. J., et al. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.03255-14 · Cited by 231

Can Multidrug-Resistant Candidaauris Be Reliably Identified in Clinical Microbiology Laboratories?

Mizusawa, M., Miller, H., Green, R., Lee, R. E., Jr., Durante, M., Perkins, R., Hewitt, C. M., Simner, P. J., Carroll, K. C., Hayden, R. T., et al. (2016) · Journal of Clinical Microbiology · doi:10.1128/jcm.02202-16 · Cited by 218

A multicenter multinational study of abdominal candidiasis: epidemiology, outcomes and predictors of mortality

Bassetti, M., Righi, E., Ansaldi, F., Merelli, M., Scarparo, C., Antonelli, M. M., Garnacho‐Montero, J., Díaz‐Martín, A., Palacios-García, I., Luzzati, R., et al. (2015) · Intensive Care Medicine · doi:10.1007/s00134-015-3866-2 · Cited by 217

Multidrug-resistant Candida auris: ‘New kid on the block’ in hospital-associated infections?

Chowdhary, A., Voss, A., & Meis, J. F. (2016) · Journal of Hospital Infection · doi:10.1016/j.jhin.2016.08.004 · Cited by 214

Epidemiological changes with potential implication for antifungal prescription recommendations for fungaemia: data from a nationwide fungaemia surveillance programme

Arendrup, M. C., Dzajic, E., Jensen, R. H., Johansen, H. K., Kjaldgaard, P., Knudsen, J. D., Kristensen, L., Leitz, C., Lemming, L. E., Nielsen, L., et al. (2013) · Clinical Microbiology and Infection · doi:10.1111/1469-0691.12212 · Cited by 206

Candida guilliermondii , an Opportunistic Fungal Pathogen with Decreased Susceptibility to Fluconazole: Geographic and Temporal Trends from the ARTEMIS DISK Antifungal Surveillance Program

Pfaller, M. A., Diekema, D. J., Méndez, M., Kibbler, C. C., Erzsebet, P., Chang, S., Gibbs, D. L., Newell, V. A., & the Global Antifungal Surveillance Group (2006) · Journal of Clinical Microbiology · doi:10.1128/jcm.00865-06 · Cited by 192

Epidemiology and risk factors for echinocandin nonsusceptible Candida glabrata bloodstream infections: data from a large multisite population-based Candidemia Surveillance Program, 2008–2014

Vallabhaneni, S., Cleveland, A. A., Farley, M. M., Harrison, L. H., Schaffner, W., Beldavs, Z. G., Derado, G., Pham, C. D., Lockhart, S. R., & Smith, R. M. (2015) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofv163 · Cited by 187

Candida aurisCandidemia in Kuwait, 2014

Emara, M., Ahmad, S., Khan, Z., Joseph, L., Al-Obaid, I., Purohit, P., & Bafna, R. (2015) · Emerging infectious diseases · doi:10.3201/eid2106.150270 · Cited by 185

Candida and invasive mould diseases in non-neutropenic critically ill patients and patients with haematological cancer

Colombo, A. L., de Almeida, J. N., Slavin, M. A., Chen, S. C. ‐., & Sorrell, T. C. (2017) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(17)30304-3 · Cited by 180

FKS Mutant Candida glabrata: Risk Factors and Outcomes in Patients With Candidemia

Beyda, N. D., John, J., Kilic, A., Alam, M. J., Lasco, T. M., & Garey, K. W. (2014) · Clinical Infectious Diseases · doi:10.1093/cid/ciu407 · Cited by 174

The Presence of an FKS Mutation Rather than MIC Is an Independent Risk Factor for Failure of Echinocandin Therapy among Patients with Invasive Candidiasis Due to Candida glabrata

Shields, R. K., Nguyen, M. H., Press, E. G., Kwa, A. L., Cheng, S., Du, C., & Clancy, C. J. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00027-12 · Cited by 171

Changing epidemiology of candidaemia in Australia

Chapman, B., Slavin, M., Marriott, D., Halliday, C., Kidd, S., Arthur, I., Bak, N., Heath, C. H., Kennedy, K., Morrissey, C. O., et al. (2016) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkw422 · Cited by 163

Fluconazole Resistance Associated with Drug Efflux and Increased Transcription of a Drug Transporter Gene, PDH1 , in Candida glabrata

Miyazaki, H., Miyazaki, Y., Geber, A., Parkinson, T., Hitchcock, C. A., Falconer, D. J., Ward, D. J., Marsden, K. E., & Bennett, J. E. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.7.1695 · Cited by 162

Notes from the Field: Ongoing Transmission of Candida auris in Health Care Facilities — United States, June 2016–May 2017

Tsay, S. V., Welsh, R. M., Adams, E. H., Chow, N. A., Gade, L., Berkow, E. L., Poirot, E., Lutterloh, E. C., Quinn, M., Chaturvedi, S., et al. (2017) · MMWR Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6619a7 · Cited by 162

Nosocomial fungemia by Candida auris: First four reported cases in continental Europe

Gaitán, A. C. R., Moret, A. M., Hontangas, J. L. L., Molina, J. M. R., López, A., Hernández-Cabezas, A., Maseres, J. B. M., Chouman-Arcas, R., Ruiz, M. D. G., Chiveli, M.-A., et al. (2017) · Revista Iberoamericana de Micología · doi:10.1016/j.riam.2016.11.002 · Cited by 158

Debaryomyces hansenii ( Candida famata ), a Rare Human Fungal Pathogen Often Misidentified as Pichia guilliermondii ( Candida guilliermondii )

Desnos‐Ollivier, M., Ragon, M., Robert, V., Raoux‐Barbot, D., Gantier, J.-C., & Dromer, F. (2008) · Journal of Clinical Microbiology · doi:10.1128/jcm.01451-08 · Cited by 154

Drug-Resistant Candida glabrata Infection in Cancer Patients

Farmakiotis, D., Tarrand, J. J., & Kontoyiannis, D. P. (2014) · Emerging Infectious Diseases · doi:10.3201/eid2011.140685 · Cited by 152

Current perspective on emergence, diagnosis and drug resistance in Candida auris

Sarma, S., & Upadhyay, S. (2017) · Infection and Drug Resistance · doi:10.2147/idr.s116229 · Cited by 151

Changing epidemiology of candidaemia in Australia

Chapman, B., Slavin, M., Marriott, D., Halliday, C., Kidd, S., Arthur, I., Bak, N., Heath, C. H., Kennedy, K., Morrissey, C. O., et al. (2017) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkx047 · Cited by 149

Loss of Mitochondrial Functions Associated with Azole Resistance in Candida glabrata Results in Enhanced Virulence in Mice

Ferrari, S., Sanguinetti, M., De Bernardis, F., Torelli, R., Posteraro, B., Vandeputte, P., & Sanglard, D. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01271-10 · Cited by 144

The ATP‐binding cassette transporter–encoding gene CgSNQ2 is contributing to the CgPDR1‐dependent azole resistance of Candida glabrata

Torelli, R., Posteraro, B., Ferrari, S., La Sorda, M., Fadda, G., Sanglard, D., & Sanguinetti, M. (2008) · Molecular Microbiology · doi:10.1111/j.1365-2958.2008.06143.x · Cited by 141

FKS Mutations and Elevated Echinocandin MIC Values among Candida glabrata Isolates from U.S. Population-Based Surveillance

Zimbeck, A. J., Iqbal, N., Ahlquist, A. M., Farley, M. M., Harrison, L. H., Chiller, T., & Lockhart, S. R. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00836-10 · Cited by 136

Candida spp. with Acquired Echinocandin Resistance, France, 2004–20101

Dannaoui, E., Desnos-Ollivier, M., Garcia-Hermoso, D., Grenouillet, F., Cassaing, S., Baixench, M.-T., Bretagne, S., Dromer, F., Lortholary, O., & the French Mycoses Study Group (2012) · Emerging infectious diseases · doi:10.3201/eid1801.110556 · Cited by 130

Molecular Identification and Antifungal Susceptibility of Yeast Isolates Causing Fungemia Collected in a Population-Based Study in Spain in 2010 and 2011

Guinea, J., Zaragoza, Ó., Escribano, P., Martín‐Mazuelos, E., Pemán, J., Sánchez, F., & Cuenca‐Estrella, M. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02155-13 · Cited by 129

Abdominal candidiasis is a hidden reservoir of echinocandin resistance

Shields, R. K., Nguyen, M. H., Press, E. G., & Clancy, C. J. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.04134-14 · Cited by 118

A Nonsense Mutation in the ERG6 Gene Leads to Reduced Susceptibility to Polyenes in a Clinical Isolate of Candida glabrata

Vandeputte, P., Tronchin, G., Larcher, G., Ernoult, E., Bergès, T., Chabasse, D., & Bouchara, J.-P. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00423-08 · Cited by 117

Facultative Sterol Uptake in an Ergosterol-Deficient Clinical Isolate of Candida glabrata Harboring a Missense Mutation in ERG11 and Exhibiting Cross-Resistance to Azoles and Amphotericin B

Hull, C. M., Parker, J. E., Bader, O., Weig, M., Gross, U., Warrilow, A. G. S., Kelly, D. E., & Kelly, S. L. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.06253-11 · Cited by 113

Epidemiology and antifungal susceptibilities of Candida spp. to six antifungal agents: results from a surveillance study on fungaemia in Germany from July 2004 to August 2005

Zepelin, M. B., Kunz, L., Rüchel, R., Reichard, U., Weig, M., & Groß, U. (2007) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkm145 · Cited by 109

Reduced Susceptibility to Polyenes Associated with a Missense Mutation in the ERG6 Gene in a Clinical Isolate of Candida glabrata with Pseudohyphal Growth

Vandeputte, P., Tronchin, G., Bergès, T., Hennequin, C., Chabasse, D., & Bouchara, J.-P. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01510-06 · Cited by 109

Caspofungin MICs correlate with treatment outcomes among patients with Candida glabrata invasive candidiasis and prior echinocandin exposure.

Shields, R. K., Nguyen, M. H., Press, E. G., Updike, C. L., & Clancy, C. J. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00136-13 · Cited by 105

Outbreak of Fungemia among Neonates Caused by Candida haemulonii Resistant to Amphotericin B, Itraconazole, and Fluconazole

Khan, Z. U., Al‐Sweih, N., Ahmad, S., Al-Kazemi, N., Khan, S. I., Joseph, L., & Chandy, R. G. (2007) · Journal of Clinical Microbiology · doi:10.1128/jcm.00222-07 · Cited by 105

Unraveling drug penetration of echinocandin antifungals at the site of infection in an intra-abdominal abscess model

Zhao, Y., Prideaux, B., Nagasaki, Y., Lee, M. H., Chen, P.-Y., Blanc, L., Ho, H., Clancy, C. J., Nguyen, M. H., Dartois, V., et al. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01009-17 · Cited by 102

Candida guilliermondii and Other Species of Candida Misidentified as Candida famata: Assessment by Vitek 2, DNA Sequencing Analysis, and Matrix-Assisted Laser Desorption Ionization–Time of Flight Mass Spectrometry in Two Global Antifungal Surveillance Programs

Castanheira, M., Woosley, L. N., Diekema, D. J., Jones, R. N., & Pfaller, M. A. (2012) · Journal of Clinical Microbiology · doi:10.1128/jcm.01686-12 · Cited by 100

Two new species in the clade: sp. nov., the ascosporic state of , and comb. nov

VAUGHANMARTINI, A., Kurtzman, C. P., MEYER, S., & ONEILL, E. (2004) · FEMS Yeast Research · doi:10.1016/j.femsyr.2004.10.008 · Cited by 95

Genetic Drivers of Multidrug Resistance in Candida glabrata

Healey, K. R., Jimenez Ortigosa, C., Shor, E., & Perlin, D. S. (2016) · Frontiers in Microbiology · doi:10.3389/fmicb.2016.01995 · Cited by 93

Two Clinical Isolates of Candida glabrata Exhibiting Reduced Sensitivity to Amphotericin B Both Harbor Mutations in ERG2

Hull, C. M., Bader, O., Parker, J. E., Weig, M., Gross, U., Warrilow, A. G. S., Kelly, D. E., & Kelly, S. L. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01145-12 · Cited by 90

First report of Candida auris in Oman: Clinical and microbiological description of five candidemia cases

Al-Siyabi, T., Busaidi, I. A., Balkhair, A., Muharrmi, Z. A., Al-Salti, M., & Adawi, B. A. (2017) · Journal of Infection · doi:10.1016/j.jinf.2017.05.016 · Cited by 88

Candida haemulonii complex: species identification and antifungal susceptibility profiles of clinical isolates from Brazil

Ramos, L. S., Figueiredo‐Carvalho, M. H. G., Barbedo, L. S., Ziccardi, M., Chaves, A. L. D. S., Zancopé‐Oliveira, R. M., Pinto, M. R., Sgarbi, D. B. D. G., Dornelas-Ribeiro, M., Branquinha, M. H., et al. (2014) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dku321 · Cited by 87

The first cases of Candida auris candidaemia in Oman

Mohsin, J., Hagen, F., Al‐Balushi, Z. A. M., de Hoog, S., Chowdhary, A., Meis, J. F. G. M., & Al‐Hatmi, A. M. S. (2017) · Mycoses · doi:10.1111/myc.12647 · Cited by 87

What do we know about Candida guilliermondii ? A voyage throughout past and current literature about this emerging yeast

Savini, V., Catavitello, C., Onofrillo, D., Masciarelli, G., Astolfi, D., Balbinot, A., Febbo, F., D’Amario, C., & D’Antonio, D. (2010) · Mycoses · doi:10.1111/j.1439-0507.2010.01960.x · Cited by 86

Comparison of the Accuracy of Two Conventional Phenotypic Methods and Two MALDI-TOF MS Systems with That of DNA Sequencing Analysis for Correctly Identifying Clinically Encountered Yeasts

Chao, Q.-T., Lee, T.-F., Teng, S.-H., Peng, L., Chen, P., Teng, L., & Hsueh, P. (2014) · PLoS ONE · doi:10.1371/journal.pone.0109376 · Cited by 82

Candida guilliermondii Fungemia in Patients with Hematologic Malignancies

Girmenia, C., Pizzarelli, G., Cristini, F., Barchiesi, F., Spreghini, E., Scalise, G., & Martino, P. (2006) · Journal of Clinical Microbiology · doi:10.1128/jcm.00356-06 · Cited by 82

Frequency of fks Mutations among Candida glabrata Isolates from a 10-Year Global Collection of Bloodstream Infection Isolates

Castanheira, M., Woosley, L. N., Messer, S. A., Diekema, D. J., Jones, R. N., & Pfaller, M. A. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01674-13 · Cited by 82

The ever-evolving landscape of candidaemia in patients with acute leukaemia: non-susceptibility to caspofungin and multidrug resistance are associated with increased mortality

Wang, E., Farmakiotis, D., Yang, D., McCue, D. A., Kantarjian, H. M., Kontoyiannis, D. P., & Mathisen, M. S. (2015) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkv087 · Cited by 82

Clinical perspectives on echinocandin resistance among Candida species

Shields, R. K., Nguyen, M. H., & Clancy, C. J. (2015) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0000000000000215 · Cited by 78

Epidemiology of antifungal resistance in human pathogenic yeasts: current viewpoint and practical recommendations for management

Farmakiotis, D., & Kontoyiannis, D. P. (2017) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2017.05.019 · Cited by 77

Fluconazole and Echinocandin resistance of Candida glabrata correlates better with antifungal drug exposure rather than with MSH2 mutator genotype in a French Cohort of patients harboring low rates of resistance.

Dellière, S., Healey, K., Gits-Muselli, M., Carrara, B., Barbaro, A., Guigue, N., Lecefel, C., Touratier, S., Desnos-Ollivier, M., Perlin, D. S., et al. (2016) · Frontiers in Microbiology · doi:10.3389/fmicb.2016.02038 · Cited by 75

Fungal CYP51 Inhibitors VT-1161 and VT-1129 Exhibit Strong In Vitro Activity against Candida glabrata and C. krusei Isolates Clinically Resistant to Azole and Echinocandin Antifungal Compounds

Schell, W. A., Jones, A. M., Garvey, E. P., Hoekstra, W. J., Schotzinger, R. J., & Alexander, B. D. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01817-16 · Cited by 74

Comparison of the Broth Microdilution (BMD) Method of the European Committee on Antimicrobial Susceptibility Testing with the 24-Hour CLSI BMD Method for Testing Susceptibility of Candida Species to Fluconazole, Posaconazole, and Voriconazole by Use of Epidemiological Cutoff Values

Pfaller, M. A., Espinel‐Ingroff, A., Boyken, L. B., Hollis, R. J., Kroeger, J. S., Messer, S. A., Tendolkar, S., & Diekema, D. J. (2011) · Journal of Clinical Microbiology · doi:10.1128/jcm.02441-10 · Cited by 73

Epidemiology and reporting of candidaemia in Belgium: a multi-centre study

Trouvé, C., Blot, S. I., Hayette, M., Jonckheere, S., Patteet, S., Rodriguez‐Villalobos, H., Symoens, F., Wijngaerden, E. V., & Lagrou, K. (2016) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-016-2841-3 · Cited by 72

Rapid Development of Candida krusei Echinocandin Resistance during Caspofungin Therapy

Forastiero, A., Garcia-Gil, V., Rivero-Menéndez, O., Garcia‐Rubio, R., Monteiro, M. C., Alastruey‐Izquierdo, A., Jordán, R., Agorio, I., & Mellado, E. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01005-15 · Cited by 70

Reliable differentiation of Meyerozyma guilliermondii from Meyerozyma caribbica by internal transcribed spacer restriction fingerprinting

Romi, W., Keisam, S., Ahmed, G., & Jeyaram, K. (2014) · BMC Microbiology · doi:10.1186/1471-2180-14-52 · Cited by 70

Candida haemulonii species complex: an emerging species in India and its genetic diversity assessed with multilocus sequence and amplified fragment-length polymorphism analyses

Kumar, A., Prakash, A., Singh, A. K., Kumar, H., Hagen, F., Meis, J. F. G. M., & Chowdhary, A. (2016) · Emerging Microbes & Infections · doi:10.1038/emi.2016.49 · Cited by 70

Multicenter Study of Epidemiological Cutoff Values and Detection of Resistance in Candida spp. to Anidulafungin, Caspofungin, and Micafungin Using the Sensititre YeastOne Colorimetric Method

Espinel‐Ingroff, A., Álvarez-Fernández, M., Cantón, R., Carver, P. L., Chen, S. C. A., Eschenauer, G. A., Getsinger, D., González, G. M., Govender, N. P., Grancini, A., et al. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01250-15 · Cited by 69

Identification of Uncommon Candida Species Using Commercial Identification Systems

Kim, T., Kweon, O. J., Kim, H. R., & Lee, M. (2016) · Journal of Microbiology and Biotechnology · doi:10.4014/jmb.1609.09012 · Cited by 69

Transient Fungemia Caused by an Amphotericin B-Resistant Isolate of Candida haemulonii

Rodero, L., Cuenca‐Estrella, M., Córdoba, S. B., Cahn, P. E., Davel, G., Kaufman, S. C., Guelfand, L. I., & Rodrı́guez-Tudela, J. L. (2002) · Journal of Clinical Microbiology · doi:10.1128/jcm.40.6.2266-2269.2002 · Cited by 65

Antifungal susceptibilities of Candida, Cryptococcus neoformans and Aspergillus fumigatus from the Asia and Western Pacific region: data from the SENTRY antifungal surveillance program (2010–2012)

Pfaller, M. A., Messer, S. A., Jones, R. N., & Castanheira, M. (2015) · The Journal of Antibiotics · doi:10.1038/ja.2015.29 · Cited by 64

Emergence of echinocandin-resistant Candida spp. in a hospital setting: a consequence of 10 years of increasing use of antifungal therapy?

Fekkar, A., Dannaoui, É., Meyer, I., Imbert, S., Brossas, J., Uzunov, M., Mellon, G., Nguyen‐Quoc, S., Guiller, E., Caumes, É., et al. (2014) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-014-2096-9 · Cited by 63

Breakthrough Candidemia Due to Multidrug-Resistant Candida glabrata during Prophylaxis with a Low Dose of Micafungin

Bizerra, F. C., Jimenez-Ortigosa, C., Souza, A. C. R., Breda, G. L., Queiroz-Telles, F., Perlin, D. S., & Colombo, A. L. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02189-13 · Cited by 63

Breakthrough C. parapsilosis and C. guilliermondii blood stream infections in allogeneic hematopoietic stem cell transplant recipients receiving long-term caspofungin therapy

Kabbara, N., Lacroix, C., Peffault de Latour, R., Socie, G., Ghannoum, M., & Ribaud, P. (2008) · Haematologica · doi:10.3324/haematol.11149 · Cited by 61

Rapid Detection of FKS -Associated Echinocandin Resistance in Candida glabrata

Zhao, Y., Nagasaki, Y., Kordalewska, M., Press, E. G., Shields, R. K., Nguyen, M. H., Clancy, C. J., & Perlin, D. S. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01574-16 · Cited by 61

Infections due to Candida haemulonii: species identification, antifungal susceptibility and outcomes

Ruan, S., Kuo, Y.-W., Huang, C., Hsiue, E. H.-C., & Hsueh, P. (2009) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2009.08.009 · Cited by 59

Identification and Antifungal Susceptibility Profiles of Candida haemulonii Species Complex Clinical Isolates from a Multicenter Study in China

Hou, X., Xiao, M., Chen, S. C.-A., Wang, H., Cheng, J., Chen, X., Xu, Z., Fan, X., Kong, F., & Xu, Y. (2016) · Journal of Clinical Microbiology · doi:10.1128/jcm.01492-16 · Cited by 57

Candida glabrata fungaemia in intensive care units

Ruan, S., Lee, L., Jerng, J., Yu, C., & Hsueh, P. (2008) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2007.01892.x · Cited by 56

Anidulafungin and Micafungin MIC Breakpoints Are Superior to That of Caspofungin for Identifying FKS Mutant Candida glabrata Strains and Echinocandin Resistance

Shields, R. K., Nguyen, M. H., Press, E. G., Updike, C. L., & Clancy, C. J. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01451-13 · Cited by 56

Rate of FKS Mutations among Consecutive Candida Isolates Causing Bloodstream Infection

Shields, R. K., Nguyen, M. H., Press, E. G., Cumbie, R., Driscoll, E., Pasculle, A. W., & Clancy, C. J. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01973-15 · Cited by 55

Candida haemuloniiComplex Species, Brazil, January 2010–March 2015

de Almeida, J. N., Assy, J. G. P. L., Levin, A. S., Negro, G. M. B. D., Giudice, M. C., Tringoni, M. P., Thomaz, D. Y., Motta, A. L., Abdala, E., Pierrotti, L. C., et al. (2016) · Emerging infectious diseases · doi:10.3201/eid2203.151610 · Cited by 55

Candida guilliermondii Complex Is Characterized by High Antifungal Resistance but Low Mortality in 22 Cases of Candidemia

Marcos-Zambrano, L. J., Puig‐Asensio, M., Pérez‐García, F., Escribano, P., Sánchez‐Carrillo, C., Zaragoza, Ó., Padilla, B., Cuenca‐Estrella, M., Almirante, B., Martín-Gómez, M. T., et al. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00099-17 · Cited by 54

Editorial Commentary: Candida glabrata and FKS Mutations: Witnessing the Emergence of the True Multidrug-Resistant Candida

Ostrosky‐Zeichner, L. (2013) · Clinical Infectious Diseases · doi:10.1093/cid/cit140 · Cited by 51

Multicenter Study of Anidulafungin and Micafungin MIC Distributions and Epidemiological Cutoff Values for Eight Candida Species and the CLSI M27-A3 Broth Microdilution Method

Pfaller, M. A., Espinel‐Ingroff, A., Bustamante, B., Cantón, R., Diekema, D. J., Fothergill, A., Fuller, J., González, G. M., Guarro, J., Lass‐Flörl, C., et al. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02020-13 · Cited by 51

Echinocandin resistance and population structure of invasive Candida glabrata isolates from two university hospitals in Germany and Austria

Klotz, U., Schmidt, D., Willinger, B., Steinmann, E., Buer, J., Rath, P., & Steinmann, J. (2016) · Mycoses · doi:10.1111/myc.12472 · Cited by 51

Development of a Luminex-Based Multiplex Assay for Detection of Mutations Conferring Resistance to Echinocandins in Candida glabrata

Pham, C. D., Bolden, C. B., Kuykendall, R. J., & Lockhart, S. R. (2013) · Journal of Clinical Microbiology · doi:10.1128/jcm.03378-13 · Cited by 50

Echinocandin Resistance in Two Candida haemulonii Isolates from Pediatric Patients

Muro, M. D., Motta, F. D. A., Burger, M., Melo, A. S. D. A., & Dalla-Costa, L. M. (2012) · Journal of Clinical Microbiology · doi:10.1128/jcm.01136-12 · Cited by 47

Identification of Candida haemulonii Complex Species: Use of ClinProToolsTM to Overcome Limitations of the Bruker BiotyperTM, VITEK MSTM IVD, and VITEK MSTM RUO Databases

Grenfell, R. C., da Silva, A. R., Negro, G. M. B. D., Munhoz, R. B., Gimenes, V. M. F., Assis, D. M., Rockstroh, A. C., Motta, A. L., Rossi, F., Juliano, L., et al. (2016) · Frontiers in Microbiology · doi:10.3389/fmicb.2016.00940 · Cited by 44

Echinocandin Resistance in Candida Species Isolates from Liver Transplant Recipients

Prigent, G., Aït‐Ammar, N., Levesque, É., Fekkar, A., Costa, J., Anbassi, S. E., Foulet, F., Duvoux, C., Merle, J., Dannaoui, É., et al. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01229-16 · Cited by 44

EUCAST Technical Note on Candida and micafungin, anidulafungin and fluconazole

Cavling Arendrup, M., Cuenca‐Estrella, M., Lass‐Flörl, C., Hope, W. W., & The European Committee on Antimicrobial Susceptibility Testing – Subcommittee on Antifungal Susceptibility Testing (EUCAST‐AFST) (2014) · Mycoses · doi:10.1111/myc.12170 · Cited by 43

Systematic review and new insights into the molecular characterization of the Candida rugosa species complex

Padovan, A. C. B., Melo, A. S. D. A., & Colombo, A. L. (2013) · Fungal Genetics and Biology · doi:10.1016/j.fgb.2013.10.007 · Cited by 43

Evaluation of Caspofungin Susceptibility Testing by the New Vitek 2 AST-YS06 Yeast Card Using a Unique Collection of FKS Wild-Type and Hot Spot Mutant Isolates, Including the Five Most Common Candida Species

Astvad, K. M., Perlin, D. S., Johansen, H. K., Jensen, R. H., & Arendrup, M. C. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01382-12 · Cited by 43

Catheter-related Candidemia Caused by Candida haemulonii in a Patient in Long-term Hospital Care

Kim, S., Ko, K. S., Moon, S. Y., Lee, M. S., Lee, M. Y., & Son, J. S. (2011) · Journal of Korean Medical Science · doi:10.3346/jkms.2011.26.2.297 · Cited by 36

Emergence of multiple resistance profiles involving azoles, echinocandins and amphotericin B in Candida glabrata isolates from a neutropenia patient with prolonged fungaemia

Cho, E., Shin, J. H., Kim, S. H., Kim, H., Park, J. S., Sung, H., Kim, M., & Im, H. J. (2014) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dku518 · Cited by 36

Species distribution and antifungal susceptibility of bloodstream fungal isolates in paediatric patients in Mexico: a nationwide surveillance study

González, G. M., Treviño‐Rangel, R. D. J., Palma‐Nicolás, J. P., Martinez, C. R., González‐González, J. G., Ayala, J., Caballero, A., Morfín‐Otero, R., Rodríguez-Noriega, E., Velarde, F., et al. (2013) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkt283 · Cited by 35

Validation of 24-Hour Posaconazole and Voriconazole MIC Readings versus the CLSI 48-Hour Broth Microdilution Reference Method: Application of Epidemiological Cutoff Values to Results from a Global Candida Antifungal Surveillance Program

Pfaller, M. A., Boyken, L. B., Hollis, R. J., Kroeger, J. S., Messer, S. A., Tendolkar, S., & Diekema, D. J. (2011) · Journal of Clinical Microbiology · doi:10.1128/jcm.02437-10 · Cited by 34

Molecular Confirmation of the Relationship between Candida guilliermondii Fks1p Naturally Occurring Amino Acid Substitutions and Its Intrinsic Reduced Echinocandin Susceptibility

Dudiuk, C., Macedo, D., Leonardelli, F., Theill, L., Cabeza, M. S., Gamarra, S. P., & García‐Effrón, G. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02644-16 · Cited by 33

Clinical features of patients with infections caused by Candida guilliermondii and Candida fermentati and antifungal susceptibility of the isolates at a medical centre in Taiwan, 2001-10

Chen, Y., Huang, S., Tang, J., Tsay, W., Yao, M., Ko, B., Chou, W., Tien, H., & Hsueh, P. (2013) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkt214 · Cited by 31

Identification and Antifungal Susceptibility Profile of Candida guilliermondii and Candida fermentati from a Multicenter Study in China

Cheng, J.-W., Yu, S.-Y., Xiao, M., Wang, H., Kudinha, T., Kong, F., & Xu, Y. (2016) · Journal of Clinical Microbiology · doi:10.1128/jcm.00938-16 · Cited by 29

A case of Candida haemulonii osteitis: clinical features, biochemical characteristics, and antifungal resistance profile

Crouzet, J., Sotto, A., Picard, E., Lachaud, L., & Bourgeois, N. (2011) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2011.03471.x · Cited by 28

Relationship between respiration deficiency and azole resistance in clinical Candida glabrata

Peng, Y., Dong, D., Jiang, C., Yu, B., Wang, X., & Ji, Y. (2012) · FEMS Yeast Research · doi:10.1111/j.1567-1364.2012.00821.x · Cited by 27

Clinical features, antifungal susceptibility, and outcome of Candida guilliermondii fungemia: An experience in a tertiary hospital in mid-Taiwan

Tseng, T.-Y., Chen, T., Ho, C., Lin, P., Chou, C.-H., Tsai, C.-T., Wang, J.-H., Chi, C.-Y., & Ho, M. (2017) · Journal of Microbiology Immunology and Infection · doi:10.1016/j.jmii.2016.08.015 · Cited by 27

Candidaemia Observed at a University Hospital in Milan (Northern Italy) and Review of Published Studies from 2010 to 2014

Milazzo, L., Peri, A. M., Mazzali, C., Grande, R., Cazzani, C., Ricaboni, D., Castelli, A., Raimondi, F., Magni, C. F., Galli, M., et al. (2014) · Mycopathologia · doi:10.1007/s11046-014-9786-9 · Cited by 26

Pan-azole-Resistant Candida guilliermondii from a Leukemia Patient’s Silent Funguria

Savini, V., Catavitello, C., Marzio, I. D., Masciarelli, G., Astolfi, D., Balbinot, A., Bianco, A., Pompilio, A., Bonaventura, G. D., D’Amario, C., et al. (2010) · Mycopathologia · doi:10.1007/s11046-010-9278-5 · Cited by 24

Two echinocandin-resistant Candida glabrata FKS mutants from South Africa

Naicker, S. D., Magobo, R. E., Zulu, T. G., Maphanga, T. G., Luthuli, N., Lowman, W., & Govender, N. P. (2016) · Medical Mycology Case Reports · doi:10.1016/j.mmcr.2016.03.004 · Cited by 24

Neonatal Candidemia Caused by Candida haemulonii: Case Report and Review of Literature

Silva, C. M., Carvalho-Parahym, A. M. R., Macêdo, D. P. C., de Lima-Neto, R. G., Francisco, E. C., Melo, A. S. D. A., Silva, M. D. C. M., Jucá, M. B., de Mello, L. R. B., Amorim, R. J. M., et al. (2015) · Mycopathologia · doi:10.1007/s11046-015-9872-7 · Cited by 23

Breakthrough Invasive Candida glabrata in Patients on Micafungin: a Novel FKS Gene Conversion Correlated with Sequential Elevation of MIC

Saraya, T., Tanabe, K., Araki, K., Yonetani, S., Makino, H., Watanabe, T., Tsujimoto, N., Takata, S., Kurai, D., Ishii, H., et al. (2014) · Journal of Clinical Microbiology · doi:10.1128/jcm.03593-13 · Cited by 22

Evaluation of the New Micronaut- Candida System Compared to the API ID32C Method for Yeast Identification

Szabó, Z., Tóth, B., Kovács, M., Kardos, G., Maráz, A., Rozgonyi, F., & Majoros, L. (2008) · Journal of Clinical Microbiology · doi:10.1128/jcm.02350-07 · Cited by 22

Clinical Characteristics, Laboratory Identification, and In Vitro Antifungal Susceptibility of Yarrowia (Candida) lipolytica Isolates Causing Fungemia: a Multicenter, Prospective Surveillance Study

Zhao, Y. Y., Chan, J. F., Tsang, C., Wang, H., Guo, D., Pan, Y., Xiao, Y., Yue, N., Chen, J. H.-K., Lau, S. K. P., et al. (2015) · Journal of Clinical Microbiology · doi:10.1128/jcm.01985-15 · Cited by 21

CAND-LO 2014–15 study: changing epidemiology of candidemia in Lombardy (Italy)

Prigitano, A., Cavanna, C., Passera, M., Ossi, C. M., Sala, E., Lombardi, G., Grancini, A., Luca, C. D., Bramati, S., Gelmi, M., et al. (2016) · Infection · doi:10.1007/s15010-016-0951-6 · Cited by 21

Activity of Combined Antifungal Agents Against Multidrug-Resistant Candida glabrata Strains

Denardi, L. B., Keller, J. T., Oliveira, V., Mario, D. A. N., Santúrio, J. M., & Alves, S. H. (2017) · Mycopathologia · doi:10.1007/s11046-017-0141-9 · Cited by 21

Fungemia due to Candida guilliermondii in a pediatric and adult population during a 12-year period

Pemán, J., Bosch, M., Cantón, E., Viudes, A., Jarque, I., García, M. G., García‐Martínez, J., & Gobernado, M. (2007) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2007.07.014 · Cited by 20

Discontinuation of echinocandin and azole treatments led to the disappearance of an FKS alteration but not azole resistance during clonal Candida glabrata persistent candidaemia

Imbert, S., Castain, L., Pons, A., Jacob, S., Meyer, I., Palous, M., Vézinet, C., Langeron, O., Hennequin, C., Monsel, A., et al. (2016) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2016.07.025 · Cited by 18

Dose escalation studies with caspofungin against Candida glabrata

Domán, M., Kovács, R., Perlin, D. S., Kardos, G., Gesztelyi, R., Juhász, B., Bozó, A., & Majoros, L. (2015) · Journal of Medical Microbiology · doi:10.1099/jmm.0.000116 · Cited by 13

Molecular epidemiology and azole resistance mechanism study of Candida guilliermondii from a Chinese surveillance system

Cheng, J.-W., Liao, K., Kudinha, T., Yu, S.-Y., Xiao, M., Wang, H., Kong, F., & Xu, Y. (2017) · Scientific Reports · doi:10.1038/s41598-017-01106-7 · Cited by 13

Rare occurrence of fatalCandida haemuloniiperitonitis in a diabetic CAPD patient

Yuvaraj, A., Rohit, A., Koshy, P. J., Nagarajan, P., Nair, S., & Abraham, G. (2014) · Renal Failure · doi:10.3109/0886022x.2014.944067 · Cited by 10

Development of Two Molecular Approaches for Differentiation of Clinically Relevant Yeast Species Closely Related to Candida guilliermondii and Candida famata

Feng, X., Wu, J., Ling, B., Yang, X., Liao, W., Pan, W., & Yao, Z. (2014) · Journal of Clinical Microbiology · doi:10.1128/jcm.01297-14 · Cited by 10

Candida guilliermondii continuous ambulatory peritoneal dialysis peritonitis confirmed by 16s rRNA sequencing

Kim, M., Bae, E. H., Kim, S. W., & Kwon, S. (2016) · Nephrology · doi:10.1111/nep.12650 · Cited by 2

Scientific Opinion on the update of the list of QPS‐recommended biological agents intentionally added to food or feed as notified to EFSA†

(BIOHAZ), E. P. O. B. H., Ricci, A., Allende, A., Bolton, D., Chemaly, M., Davies, R., Gironés, R., Herman, L., Koutsoumanis, K. P., Lindqvist, R., et al. (2017) · EFSA Journal · doi:10.2903/j.efsa.2017.4664 · Cited by 467

Emerging Fungal Infections: New Patients, New Patterns, and New Pathogens

Friedman, D. Z. P., & Schwartz, I. S. (2019) · Journal of Fungi · doi:10.3390/jof5030067 · Cited by 369

Scientific Opinion on the update of the list of QPS‐recommended biological agents intentionally added to food or feed as notified to EFSA (2017–2019)

(BIOHAZ), E. P. O. B. H., Koutsoumanis, K., Allende, A., Alvarez‐Ordóñez, A., Bolton, D., Bover‐Cid, S., Chemaly, M., Davies, R., De Cesare, A., Hilbert, F., et al. (2020) · EFSA Journal · doi:10.2903/j.efsa.2020.5966 · Cited by 294

Candida auris: epidemiology, diagnosis, pathogenesis, antifungal susceptibility, and infection control measures to combat the spread of infections in healthcare facilities

Ahmad, S., & Alfouzan, W. (2021) · Microorganisms · doi:10.3390/microorganisms9040807 · Cited by 269

Candida glabrata: pathogenicity and resistance mechanisms for adaptation and survival

Hassan, Y., Chew, S. Y., & Than, L. T. L. (2021) · Journal of Fungi · doi:10.3390/jof7080667 · Cited by 170

The Candida auris Alert: Facts and Perspectives

Lamoth, F., & Kontoyiannis, D. P. (2017) · The Journal of Infectious Diseases · doi:10.1093/infdis/jix597 · Cited by 100

Candida auris—the growing menace to global health

Lone, S. A., & Ahmad, A. (2019) · Mycoses · doi:10.1111/myc.12904 · Cited by 216

Candida auris: A rapidly emerging cause of hospital-acquired multidrug-resistant fungal infections globally

Chowdhary, A., Sharma, C., & Meis, J. F. (2017) · PLOS Pathogens · doi:10.1371/journal.ppat.1006290 · Cited by 750

Candida auris : An emerging multidrug-resistant pathogen of global significance

Khan, Z., & Ahmad, S. (2017) · Current Medicine Research and Practice · doi:10.1016/j.cmrp.2017.11.004 · Cited by 24

Candida auris : A systematic review and meta‐analysis of current updates on an emerging multidrug‐resistant pathogen

Sekyere, J. O. (2018) · MicrobiologyOpen · doi:10.1002/mbo3.578 · Cited by 317